Thankfully, some trial oversight committees had the sense to check if there was any evidence of harm in their primary data. https://www.recoverytrial.net/news/

Thankfully, some trial oversight committees had the sense to check if there was any evidence of harm in their primary data. https://www.recoverytrial.net/news/recruitment-to-the-recovery-trial-continues-as-planned https://www.recoverytrial.net/news/recruitment-to-the-recove... > ‘On Saturday 23 May, the independent Data Monitoring Committee conducted an urgent review of the data that we have collected so far on the effects of hydroxychloroquine on mortality among patients admitted to hospital with COVID-19. The Committee concluded that there is “no cogent reason to suspend recruitment for safety reasons.” > ‘The Committee found that the effects of hydroxychloroquine on mortality reported in the analysis by Mehra were not consistent with those observed in the RECOVERY Trial. The Committee therefore recommended that the trial continue recruitment without interruption, a recommendation that was endorsed on Sunday by the MHRA.